A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Though counting calories works for some people, it can be time-consuming and stressful. Plus, it can lead to eating disorder symptoms and an unhealthy relationship with food. Luckily, you don’t need ...

Forbes contributors publish independent expert analyses and insights. Across the earlier articles in this series, we developed a framework for understanding why weight loss and regulation is far more ...

Obesity rates may exceed 50% globally in the coming decades, with India seeing rising childhood obesity. Experts say new ...

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...